Skip to content

Author

Vicente R Castro

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Rituximab in Progressive Connective Tissue Disease-Associated Interstitial Lung Disease: A Multicenter Real-World Cohort Study.

INTRODUCTION Rituximab has emerged as a viable rescue therapy for connective tissue disease-associated interstitial lung disease (CTD-ILD), which is resistant to standard immunosuppression. However, real-world data on long-term lung function trajectories following rituximab in individuals with objectively verified prog...

Agustín Patrone, J. Enghelmayer, María Otaola et al. · 0 citations
Review 2026

[Early diagnosis in interstitial lung diseases and its impact].

Overall, early diagnosis in fibrosing ILD should be regarded as a therapeutic intervention in itself, capable of modifying the natural history of the disease, improving quality of life, and reducing both the economic and emotional burden for patients and healthcare systems.

Vicente R Castro, Florencia M Villarroel, Silvia Quadrelli · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.